DAVID MARKS: Open Payments
NPI 1841486149 · ANSONIA, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$573 in 33 payments from 7 companies in 2025. Trend: 2023 $1,265 · 2024 $1,018 · 2025 $573
Food & beverage: $573
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $223 |
| Novartis Pharmaceuticals Corporation | 5 | $124 |
| GlaxoSmithKline, LLC. | 4 | $86 |
| AstraZeneca Pharmaceuticals LP | 3 | $79 |
| Exact Sciences Corporation | 1 | $26 |
| Braeburn Inc. | 1 | $21 |
| Intra-Sana Laboratories | 1 | $15 |
Products named: LEQVIO, UBRELVY, QULIPTA, BREZTRI, The Cologuard Plus Collection Kit, NUCALA, VRAYLAR, SHINGRIX.
Industry payments across CT — which companies pay providers there.
